Ruane Clinical Research Group, Inc. (Site 5624)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• HIV

Closed trials

• Completed

  Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)

  NCT04233879· Phase 3· Merck Sharp & Dohme LLC· Source